Exploding use of regular Asprin users at play alsoInvestors may becoming aware how significant the study recently out of the UK showing strong preventative benefits for taking Asprin regularily for both CANCER and CARDIOVASCULAR problems...Firstly this hits the sweet spot for Yosprala since it is aimed at the regular users and not the pain side of the Asprin market as much. Secondly, the Cancer and Cardiovascular markets are absolutely mamoth individually, but we are combining them here, as the positive benefits were for both but especially cancer... What could this market be worth..Potentially too staggering to imagine but combined , this market is likely several hundred billion dollar market in North America alone...